Skip to main content
Ziga Cizman
( out of 78 reviews )

Ziga Cizman, MD, MPH

Languages spoken: English

Clinical Locations

University of Utah Hospital

Radiology
Salt Lake City
801-581-2967
  • Ziga Cizman MD, MPH is an assistant professor in Interventional Radiology at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI). Dr. Cizman’s specializes in minimally invasive treatment of cancers spread to the liver, lung, bones and soft tissue. His other areas of interest include treatment of Desmoids, prostate artery embolization, renal and liver transplant intervention and management of portal hypertension. Dr. Cizman is among the first in the area to perform minimally invasive treatments, through an artery in the wrist, improving patient comfort and speeding recovery.

    Dr. Cizman obtained his undergraduate degree from University of Pennsylvania and his medical degrees from Thomas Jefferson University. While enrolled in medical school he pursued an MPH at Johns Hopkins University Bloomberg School of Public Health, where he developed an interest in Interventional Radiology. After graduating from medical school, Dr. Cizman completed his surgical internship at the University of East Carolina and then traveled westward to the University of North Carolina-Chapel Hill for radiology residency and southward to Emory for an Interventional Radiology Fellowship.

    Dr. Cizman is currently accepting new patients at both the University of Utah and Huntsman Cancer Center.

    Board Certification

    American Board of Radiology (Vascular and Interventional Radiology)

    Patient Rating

    4.9 /5
    ( out of 78 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    June 09, 2025
    HUNTSMAN CANCER CENTER

    He is great with me. He is informed and "well versed" in his skills and knowledge. I would give his a very high 10 out of 10!!

    June 08, 2025
    HUNTSMAN CANCER CENTER

    Spent time to explain everything in a way that was easy to understand. Very careing manor

    May 14, 2025
    HUNTSMAN CANCER CENTER

    Dr. Cizman took my case and went outside the box to find a way to treat my ÒuncommonÓ tumor. If it wasnÕt for him I believe I would have spent my life on pain meds and limited use of my arm. His persistance has given me my health back. He is a great doctor. [NAME REMOVED]

    April 12, 2025
    HUNTSMAN CANCER CENTER

    Outstanding provider.

    February 05, 2025
    HUNTSMAN CANCER CENTER

    Awesome doctor, very straight forward which I truly appreciate. I feel very at ease with him, appreciate his knowledge and his honest answers and opinion. Appreciate that he doesn't use a lot of doctor jargon, he explains things in a way that I can understand.

    January 16, 2025
    HUNTSMAN CANCER CENTER

    He's Great!

    December 11, 2024
    HUNTSMAN CANCER CENTER

    yes, i would like to my friends about my story

    December 11, 2024
    HUNTSMAN CANCER CENTER

    Dr. Cizman is fantastic! He is smart, personable, answers my questions, listens to my concerns--I feel totally confident, and so grateful, to have him on my team!!!

    November 01, 2024
    HUNTSMAN CANCER CENTER

    Dr Cizman is an excellent doctor! He has been apart of my care for 3 years now and I trust him with my life!

  • Ziga Cizman MD, MPH is an assistant professor in Interventional Radiology at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI). Dr. Cizman’s specializes in minimally invasive treatment of cancers spread to the liver, lung, bones and soft tissue. His other areas of interest include treatment of Desmoids, prostate artery embolization, renal and liver transplant intervention and management of portal hypertension. Dr. Cizman is among the first in the area to perform minimally invasive treatments, through an artery in the wrist, improving patient comfort and speeding recovery.

    Dr. Cizman obtained his undergraduate degree from University of Pennsylvania and his medical degrees from Thomas Jefferson University. While enrolled in medical school he pursued an MPH at Johns Hopkins University Bloomberg School of Public Health, where he developed an interest in Interventional Radiology. After graduating from medical school, Dr. Cizman completed his surgical internship at the University of East Carolina and then traveled westward to the University of North Carolina-Chapel Hill for radiology residency and southward to Emory for an Interventional Radiology Fellowship.

    Dr. Cizman is currently accepting new patients at both the University of Utah and Huntsman Cancer Center.

    Board Certification and Academic Information

    Academic Departments Radiology & Imaging Sciences -Associate Professor (Clinical)
    Board Certification
    American Board of Radiology (Vascular and Interventional Radiology)

    Education history

    Fellowship Interventional Radiology - Emory University School of Medicine Fellow
    Chief Resident Radiology - University of North Carolina School of Medicine Chief Resident
    Residency Radiology - University of North Carolina School of Medicine Resident
    Internship Surgery - East Carolina University/Pitt County Memorial Hospital Intern
    Graduate Training Johns Hopkins Bloomberg School of Public Health M.P.H.
    Professional Medical Medicine - Sidney Kimmel Medical College of Thomas Jefferson University M.D.
    Undergraduate Biology Basis of Behavior Program - University of Pennsylvania B.A.

    Selected Publications

    Journal Article

    1. Geranios KC, Littau MS, Park SS, Baker TB, Gilcrease GW, Cizman Z, Smith T, Baker MS (2024). Localized hepatocellular carcinoma: Is liver-directed therapy alone as efficacious as surgical resection? Surgery, 179, 108939. (Read full article)
    2. Son L, Couldwell M, Anand K, Cizman Z, Smith T (2024). Pulmonary artery pseudoaneurysm secondary to right heart catheterization during placement of a left atrial appendage closure device. Radiol Case Rep, 20(1), 297-303. (Read full article)
    3. Cizman Z, Zachery Paden W, Smith T, Wilhite S, Strain D, Saad W (2024). Endovascular retrieval of a migrated covered stent from the pulmonary artery. Radiol Case Rep, 19(6), 2117-2120. (Read full article)
    4. Cizman Z, Saad W (2023). Transplant Hepatic Artery Complications. Tech Vasc Interv Radiol, 26(4), 100923. (Read full article)
    5. Oesterling AE, Kenlan DE, Cizman Z (2023). Coronary Artery Air Embolism in the Non-operating Room Anesthesia Setting: Reply. Anesthesiology. (Read full article)
    6. Oesterling AE, Kenlan DE, Cizman Z (2022). Coronary Artery Air Embolism in the Non-operating room Anesthesia Setting. Anesthesiology, 138(2), 216-217. (Read full article)
    7. Kaufman C, Adkison G, Smith T, Jenkins L, Cizman Z (2022). Single Institution Outcome of Minimally Invasive Enterocutaneous Fistula Management Utilizing the Biodesign® Fistula Plug. Cardiovasc Intervent Radiol, 45(6), 846-851. (Read full article)
    8. Weber SN, Al-Dulaimi R, Quencer KB, Kaufman C, Cizman Z, Eiswirth P, Brown KT (2022). Paracentesis: Faster and easier using the RenovaRP® pump. Diagn Interv Radiol, 28(2), 166-170. (Read full article)
    9. Smith TA, Hardman RL, Jenkins L, Marashi K, OHara R, Cizman Z (2020). Extracellular Matrix Enterocutaneous Fistula Plugs Show Promise for Low-Flow Colocutaneous and Enterocutaneous Fistulae. J Vasc Interv Radiol, 32(1), 128-134. (Read full article)
    10. Quencer KB, Tadros AS, Marashi KB, Cizman Z, Reiner E, OHara R, Oklu R (2018). Bleeding after Percutaneous Transhepatic Biliary Drainage: Incidence, Causes and Treatments. J Clin Med, 7(5). (Read full article)
    11. Cizman Z, Isaacson A, Burke C (2016). Short- to Midterm Safety and Efficacy of Prostatic Artery Embolization: A Systematic Review. J Vasc Interv Radiol, 27(10), 1487-1493.e1. (Read full article)
    12. Cizman Z, Hammer M, Mollard B, Morgan R, Ballenger Z, Runner GJ, Heitkamp DE, Resnik C (2016). A Resident Perspective on Adding Value as Radiologists. Acad Radiol, 23(4), 517-20. (Read full article)
    13. Hammer MM, Shetty AS, Cizman Z, McWilliams SR, Holt DK, Gould JE, Evens RG (2015). Results of the 2015 Survey of the American Alliance of Academic Chief Residents in Radiology. Acad Radiol, 22(10), 1308-16. (Read full article)
    14. Rodriguez R, Cizman Z, Hong K, Koliatsos A, Georgiades C (2011). Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma. Cardiovasc Intervent Radiol, 34(3), 573-8. (Read full article)

    Review

    1. Anand K, Cizman Z, Smith T, Strain D, Patel S, Campsen J, Baker T, Saad W (2023). Persistent Bleeding after Coil Embolization of a Pancreatic Transplant Pseudoaneurysm: Should Covered Stents Be the Primary Management? [Review]. Semin Intervent Radiol, 40(3), 283-285. (Read full article)

    Case Report

    1. Cizman Z, Paden WZ, Smith T, Wilhite S, Strain D, Saad W (2024). Endovascular retrieval of a migrated covered stent from the pulmonary artery. Radiol Case Rep, 19(6), 2117-2120.
    2. Fall D, Smith T, Prazak AM, Cizman Z, Iravani A (2023). Acute decompensation of patient following an outpatient CT-guided needle biopsy: A case report. Radiol Case Rep, 18(3), 1261-1263. (Read full article)

    Letter

    1. Smith T, Cizman Z, Wilhite S, Strain D, Ray C, Saad W (2025). Transjugular Intrahepatic Portosystemic Shunt Access Utilizing a 16-F Balloon Valve Sheath Allowing Large-Bore Thrombectomy and Multiple Parallel Catheter Thrombolysis for Acute Portomesenteric Thrombosis. [Letter to the editor]. J Vasc Interv Radiol, 36(7), 1212-1215. (Read full article)
    2. Smith T Paden WZ Cizman Z Strain D Saad W (2024). A New Indication for Percutaneous Cholecystostomy: Methotrexate Toxicity Due to Gallbladder Sequestration [Letter to the editor]. J Vasc Interv Radiol, 35(2), P320-321.